Application no. and date | 18171522.8 (espacenet) (Federated) (European Patent Register), 20130325 | Patent/reg. no. and date | DK/EP 3427723, 20200805 | Publication date | 20190116 | Priority no. and date | WO PCT/EP2012/001319, 20120326 | EP pub. no. and date |
EP 3427723 20190116 | Effective date | | Applicant/owner | TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH, Freiligrathstrasse 12
55131 Mainz, DE, BioNTech SE, An der Goldgrube 12
55131 Mainz, DE | Applicant ref. no. | V2009-074-DK | Inventor | KREITER, Sebastian, Külbstrasse 16
55131 Mainz, DE, SAHIN, Ugur, Philipp-von-Zabern-Platz 1
55116 Mainz, DE, Haas, Heinrich, Schaftriebweg 68
55131 Mainz, DE, DIKEN, Mustafa, Hindenburgstrasse 11
55118 Mainz, DE, FRITZ, Daniel, Heidelbergerfassgasse 12
55116 Mainz, DE, MENG, Martin, Hölderlinstrasse 4
55131 Mainz, DE, REUTER, Kerstin, Mühlstrasse 40
64283 Darmstadt, DE, KRANZ, Lena Mareen, Forsterstrasse 20
55118 Mainz, DE | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61K 48/00 (2006.01) , A61K 9/127 (2006.01) | Title | RNA-FORMULERING TIL IMMUNTERAPI | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|